- Home
- AEI vs ATHA Comparison
AEI vs ATHA Comparison
Compare AEI & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEI
- ATHA
- Stock Information
- Founded
- AEI 2014
- ATHA 2011
- Country
- AEI United States
- ATHA United States
- Employees
- AEI N/A
- ATHA N/A
- Industry
- AEI Building operators
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- AEI Real Estate
- ATHA Health Care
- Exchange
- AEI Nasdaq
- ATHA Nasdaq
- Market Cap
- AEI 13.6M
- ATHA 14.8M
- IPO Year
- AEI N/A
- ATHA 2020
- Fundamental
- Price
- AEI $3.18
- ATHA $0.38
- Analyst Decision
- AEI
- ATHA Hold
- Analyst Count
- AEI 0
- ATHA 1
- Target Price
- AEI N/A
- ATHA $0.50
- AVG Volume (30 Days)
- AEI 1.5M
- ATHA 177.7K
- Earning Date
- AEI 11-13-2025
- ATHA 11-06-2025
- Dividend Yield
- AEI N/A
- ATHA N/A
- EPS Growth
- AEI N/A
- ATHA N/A
- EPS
- AEI N/A
- ATHA N/A
- Revenue
- AEI $16,069,911.00
- ATHA N/A
- Revenue This Year
- AEI N/A
- ATHA N/A
- Revenue Next Year
- AEI N/A
- ATHA N/A
- P/E Ratio
- AEI N/A
- ATHA N/A
- Revenue Growth
- AEI 74.28
- ATHA N/A
- 52 Week Low
- AEI $0.70
- ATHA $0.22
- 52 Week High
- AEI $4.55
- ATHA $0.83
- Technical
- Relative Strength Index (RSI)
- AEI 59.29
- ATHA 46.23
- Support Level
- AEI $2.21
- ATHA $0.35
- Resistance Level
- AEI $4.55
- ATHA $0.39
- Average True Range (ATR)
- AEI 0.65
- ATHA 0.02
- MACD
- AEI 0.18
- ATHA -0.00
- Stochastic Oscillator
- AEI 57.19
- ATHA 50.00
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.